PharmaBoardroom

Five Cell & Gene Companies to Know in Europe

The cell and gene therapy market was valued at USD 6 billion in 2017 and is projected to exceed USD 35 billion in value by 2026. Moreover, these…

Luis Calderon – General Manager, Biogen Mexico

Biogen Mexico’s Luis Calderon discusses establishing the affiliate, the opportunities apparent in the Mexican neurodegenerative disease market, and…

Alex Zhavoronkov – CEO, Insilico Medicine

Alex Zhavoronkov, CEO of Insilico Medicine, lifts the lid on the role of AI in target discovery, identification, and validation. He also offers his…

Indian Pharma Manufacturing: Back in Business

COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and active pharmaceutical ingredients for…

Desmond Hau – CEO, Pangenia Group

Dr Desmond Hau, CEO of Pangenia Inc, sits down with PharmaBoardroom to shed light on the company’s progress since taking the reins three years ago.…

European Medicines Agency (EMA) Advanced Therapy Medicinal…

A full list of EMA ATMP approvals. Made with Visme Infographic Maker

US FDA Approved Cell & Gene Therapy Products

A full list of the cell and gene therapy products approved by the US FDA. Made with Visme Infographic Maker

Japanese PMDA Regenerative Medicine Approvals

A full list of the regenerative medicine products that have been approved by the PMDA, Japan's drug regulatory body. Made with Visme…

Abbas Virji & Shalina Clifford – Co-CEOs, Shalina…

Sub-Saharan Africa might not be considered among the top destinations for the global pharmaceutical industry, but Shalina Healthcare considers it home…

Company Spotlight: BMS Romania

With the 2019 acquisition of Celgene – one of the largest pharma acquisition in history – two of the sector’s most innovative oncology companies…

Louis Cheng – CEO, Leadgene Biomedical, Taiwan

Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody technologies, his ambitious…

Pharma Faces: Carol Lynch, Sandoz US

Carol Lynch, president of Sandoz US and head of Sandoz North America, recently spoke exclusively to PharmaBoardroom about how her diverse global…

Tagged with GEN